Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by Sotera Health Company on May 21, 2026. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were approved by stockholders:
- Election of Directors: All four Class III director nominees were elected to serve three-year terms until the 2029 annual meeting.
- Sean L. Cunningham: 226,297,734 votes For; 38,018,512 votes Withheld.
- Richard G. Kyle: 260,365,658 votes For; 3,950,588 votes Withheld.
- Vincent K. Petrella: 251,933,894 votes For; 12,382,352 votes Withheld.
- Christopher A. Simon: 253,840,543 votes For; 10,475,703 votes Withheld.
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of the Company's named executive officers with 257,678,396 votes For and 6,586,053 votes Against.
- Independent Auditor: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 267,310,915 votes For and 223,069 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the standard disclosure of the annual meeting results.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Confirm the specific terms of the three-year director tenure ending in 2029.
- Review the full proxy statement for details on the executive compensation package that received advisory approval.
- Note the relatively high number of "Withheld" votes for director Sean L. Cunningham compared to other nominees.